Articles

Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect

Cellular Oncology Unit, IRCCS Ospedale Policlinico San Martino and Department of Experimental Medicine, University of Genoa
Cellular Oncology Unit, IRCCS Ospedale Policlinico San Martino and Department of Experimental Medicine, University of Genoa
Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino
Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino
Department of Pharmacy, University of Pisa
Department of Pharmacy, University of Pisa
Department of Pharmacy, University of Pisa
Department of Pharmacy, University of Pisa
Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele
SCITECCNR
SCITECCNR
Patology Unit, IRCCS Ospedale Policlinico San Martino
Clinical Oncohematology, University of Genoa
Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino
Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico San Martino
Division of Immunology, Transplants and Infectious Diseases, IRCCS San Raffaele Scientific Institute
Vol. 107 No. 4 (2022): April, 2022 https://doi.org/10.3324/haematol.2021.278469